Aclaris Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aclaris Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $101k | 96k | 1.05 |
| 2023-09-30 | $702k | 102k | 6.85 |
| 2023-06-30 | $1.1M | 104k | 10.37 |
| 2023-03-31 | $710k | 88k | 8.09 |
| 2022-12-31 | $1.4M | 86k | 15.75 |
| 2022-09-30 | $1.3M | 84k | 15.74 |
| 2022-06-30 | $1.0M | 72k | 13.96 |
| 2022-03-31 | $952k | 55k | 17.25 |
| 2021-12-31 | $679k | 47k | 14.53 |
| 2021-09-30 | $815k | 45k | 17.99 |
| 2021-06-30 | $735k | 42k | 17.56 |
| 2020-03-31 | $54k | 52k | 1.05 |
| 2019-12-31 | $106k | 56k | 1.89 |
| 2019-09-30 | $58k | 54k | 1.07 |
| 2019-06-30 | $109k | 50k | 2.18 |
| 2019-03-31 | $275k | 46k | 5.98 |
| 2018-12-31 | $292k | 40k | 7.39 |
| 2018-09-30 | $381k | 26k | 14.53 |
| 2018-06-30 | $542k | 27k | 19.98 |
| 2018-03-31 | $389k | 22k | 17.54 |
| 2017-12-31 | $545k | 22k | 24.67 |
| 2017-09-30 | $621k | 24k | 25.82 |
| 2017-06-30 | $622k | 23k | 27.10 |
| 2017-03-31 | $349k | 12k | 29.86 |
| 2016-12-31 | $275k | 10k | 27.14 |
| 2016-09-30 | $210k | 8.2k | 25.63 |